Sponsored Links

Merck Serono: New Presentation Of Cyanokit(R) Approved By U.S. FDA PDF Print E-mail
Medical News - Bio-terrorism
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has announced that a new presentation of Cyanokit® 5 g (hydroxocobalamin) has been approved by the U.S. Food and Drug Administration (FDA). In the US, Cyanokit® is currently available in a kit comprising two 2.5 g vials as the starting dose that totals 5 g hydroxocobalamin...

Read more: Bio-terrorism / Terrorism News From Medical News Today